Bijoy Hans Ltd
Incorporated in 1985, Bijoy Hans Ltd offers medical and lifestyle solutions through physical infrastructure and digital platforms.[1]
- Market Cap ₹ 292 Cr.
- Current Price ₹ 60.9
- High / Low ₹ 60.9 / 24.2
- Stock P/E
- Book Value ₹ 12.1
- Dividend Yield 0.00 %
- ROCE -3.75 %
- ROE -3.90 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 5.04 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -32.1%
- Promoter holding is low: 30.6%
- Company has a low return on equity of -4.99% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.35 | 0.42 | 1.33 | 0.44 | 0.40 | 0.49 | 0.40 | 0.33 | 0.30 | 0.28 | 0.28 | 0.00 | |
| 0.56 | 0.67 | 1.61 | 0.72 | 0.65 | 0.74 | 0.66 | 0.63 | 0.82 | 0.64 | 0.79 | 1.37 | |
| Operating Profit | -0.21 | -0.25 | -0.28 | -0.28 | -0.25 | -0.25 | -0.26 | -0.30 | -0.52 | -0.36 | -0.51 | -1.37 |
| OPM % | -60.00% | -59.52% | -21.05% | -63.64% | -62.50% | -51.02% | -65.00% | -90.91% | -173.33% | -128.57% | -182.14% | |
| 0.29 | 0.27 | 0.23 | 0.25 | 0.23 | 0.24 | 0.21 | 0.15 | 0.14 | 0.30 | 0.74 | 0.17 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Depreciation | 0.09 | 0.07 | 0.07 | 0.08 | 0.06 | 0.05 | 0.04 | 0.03 | 0.06 | 0.05 | 0.02 | 0.00 |
| Profit before tax | -0.01 | -0.05 | -0.12 | -0.12 | -0.08 | -0.06 | -0.09 | -0.18 | -0.45 | -0.12 | 0.20 | -1.20 |
| Tax % | -100.00% | 0.00% | 0.00% | -8.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.00% | 0.00% |
| 0.00 | -0.05 | -0.13 | -0.11 | -0.08 | -0.05 | -0.09 | -0.19 | -0.44 | -0.12 | 0.14 | -1.20 | |
| EPS in Rs | 0.00 | -0.17 | -0.43 | -0.37 | -0.27 | -0.17 | -0.30 | -0.63 | -1.47 | -0.40 | 0.47 | -0.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -186% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 40% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -6% |
| 3 Years: | -5% |
| Last Year: | -4% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 48.02 |
| Reserves | 1.75 | 1.70 | 1.48 | 1.36 | 1.28 | 1.23 | 1.14 | 0.95 | 0.51 | 0.39 | 0.53 | 9.97 |
| 0.00 | 0.00 | 0.09 | 0.06 | 0.02 | 0.00 | 0.00 | 0.00 | 0.08 | 0.06 | 0.00 | 2.52 | |
| 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.06 | 7.86 | |
| Total Liabilities | 4.77 | 4.72 | 4.60 | 4.44 | 4.33 | 4.27 | 4.17 | 3.99 | 3.63 | 3.49 | 3.59 | 68.37 |
| 0.87 | 0.86 | 0.91 | 0.88 | 0.82 | 0.78 | 0.74 | 0.71 | 0.76 | 0.40 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.19 | 0.19 | 0.09 | 0.12 | 0.05 | 0.05 | 0.05 | 0.14 | 0.20 | 0.38 | 0.13 | 60.78 |
| 3.71 | 3.67 | 3.60 | 3.44 | 3.46 | 3.44 | 3.38 | 3.14 | 2.67 | 2.71 | 3.46 | 7.59 | |
| Total Assets | 4.77 | 4.72 | 4.60 | 4.44 | 4.33 | 4.27 | 4.17 | 3.99 | 3.63 | 3.49 | 3.59 | 68.37 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.13 | -0.15 | -0.40 | -0.10 | 0.02 | -0.07 | -0.01 | -0.37 | -0.26 | -0.29 | 0.22 | -7.89 | |
| 0.01 | -0.06 | -0.12 | -0.04 | 0.00 | -0.01 | 0.00 | 0.00 | -0.11 | 0.32 | 0.92 | -2.33 | |
| 0.00 | 0.00 | 0.09 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.08 | -0.02 | -0.06 | 7.53 | |
| Net Cash Flow | 0.14 | -0.22 | -0.43 | -0.14 | 0.03 | -0.10 | -0.02 | -0.37 | -0.29 | 0.01 | 1.08 | -2.69 |
| Free Cash Flow | 0.12 | -0.21 | -0.52 | -0.16 | 0.02 | -0.08 | -0.01 | -0.37 | -0.37 | 0.03 | 1.14 | -7.89 |
| CFO/OP | -62% | 60% | 143% | 36% | -8% | 28% | 4% | 123% | 50% | 81% | -49% | 576% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 83.43 | 60.83 | 30.19 | 82.95 | 91.25 | 126.63 | 118.62 | 88.48 | 109.50 | 104.29 | 0.00 | |
| Inventory Days | 116.80 | 130.36 | 51.68 | 105.97 | 102.20 | 57.03 | 121.67 | 111.09 | 69.52 | 86.90 | 0.00 | |
| Days Payable | 29.20 | 26.07 | 9.69 | 23.55 | 29.20 | 45.62 | 36.50 | 63.48 | 69.52 | 0.00 | ||
| Cash Conversion Cycle | 171.03 | 165.12 | 72.18 | 165.37 | 164.25 | 138.04 | 203.79 | 136.09 | 109.50 | 191.19 | 0.00 | |
| Working Capital Days | 521.43 | 582.26 | 255.23 | 796.36 | 894.25 | 513.98 | 438.00 | 940.15 | 206.83 | 234.64 | 273.75 | |
| ROCE % | -0.84% | -1.27% | -2.59% | -2.89% | -1.83% | -1.41% | -2.15% | -4.45% | -11.67% | -7.10% | -10.60% | -3.75% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Closing Inventory (Stock of Trading Items) Rs. Hundreds |
|
||||||||||
| Net Block (Property, Plant & Equipment) Rs. Hundreds |
|||||||||||
| Purchase of Stock-In-Trade Rs. Hundreds |
|||||||||||
| Revenue from Operations Rs. Hundreds |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Corrigendum Of Audited Financial Results For The Financial Year Ended 31 March 2026.
3 Jun - Corrected EPS error in Q4 and FY2026 standalone and consolidated audited results.
-
Corrigendum For Audited Financial Results Of 31St March 2026
3 Jun - Corrigendum to FY26 standalone and consolidated results for EPS error, dated 3 June 2026.
- Corrigendum For Financial Audited Results For 31St March 2025. 3 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
29 May - Newspaper Publications for Audited Standalone & Consolidated Financial Statement for the year ended 31 March 2026.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
28 May - Paid-up equity capital exceeded Regulation 15(2)(a) threshold on 4 March 2026; corporate governance filings now apply.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
BHL is mainly engaged in the business of trading in bulk drugs, pharmaceuticals, cosmetics, and investments.